Stay updated on Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Publications section updated to indicate items are automatically filled from PubMed. Revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:47:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Removal of the government funding lapse notice and related operating-status guidance from the page; study data and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:55:41.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Non-substantive differences seem to be formatting and layout changes across the page; there are no edits to the study purpose, criteria, interventions, or outcomes. Core details such as the title, NCT number, enrollment, locations, and status remain as before. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:54:37.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.
    Difference
    2%
    Check dated 2025-10-06T05:08:06.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T02:56:55.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.
    Difference
    0.1%
    Check dated 2025-09-14T18:59:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.